This bill amends various sections of Alaska's pharmacy laws to enhance the role of pharmacists in prescribing and administering medications, particularly in relation to pain management and opioid use. Key provisions include the requirement for pharmacists to complete training in pain management and opioid addiction as part of their licensure and continuing education. Additionally, the bill establishes standards for the independent prescribing and administration of vaccines and opioid overdose drugs, and mandates that pharmacists who prescribe or dispense controlled substances must register with the controlled substance prescription database.

The bill also introduces new definitions and clarifications regarding the practice of pharmacy, including the provision of patient care services, which now explicitly excludes the prescription of abortion-inducing drugs. Furthermore, it emphasizes the need for pharmacists to recognize their professional limits and consult with other healthcare practitioners when necessary. The changes aim to ensure that pharmacists are adequately prepared to address the complexities of medication management, particularly in the context of the ongoing opioid crisis. The effective date for these changes is set for January 1, 2026.

Statutes affected:
SB0147A, AM SB 147, introduced 03/26/2025: 08.80.030, 17.30.200, 08.80.168, 17.22.020, 17.20.085, 08.80.159, 08.80.110, 08.80.145, 08.80.165, 08.80.337, 08.80.480
SB0147B, AM CSSB 147(L&C), introduced 05/12/2025: 08.80.030, 17.30.200, 08.80.168, 17.22.020, 17.20.085, 08.80.159, 08.80.110, 08.80.145, 08.80.165, 08.80.337, 08.80.480